Table 1 Basic clinical data of subjects

Age (years)

54.3 ± 5.8

55.5 ± 6.0

0.40^*

Gender (M/F)

21/15

19/17

0.64^†

Duration of diabetes (years)

3.5 ± 1.6

3.4 ± 1.9

0.78^*

SBP (mmHg)

132.9 ± 12.8

134.1 ± 11.7

0.69^*

DBP (mmHg)

84.8 ± 10.8

83.8 ± 8.7

0.68^*

Hypertension

12 (33.3%)

15 (41.6%)

0.63⁺

FBG (mmol/L)

Pre-treatment

11.2 ± 1.9

10.8 ± 1.5

0.33^*

At 1 M follow-up

5.6 ± 0.8

5.5 ± 0.9

0.65^*

At 3 M follow-up

5.5 ± 0.9

6.0 ± 1.0

0.06^*

At 6 M follow-up

5.4 ± 1.0

5.7 ± 0.9

0.17^*

HbA1c (%)

Pre-treatment

9.7 ± 1.1

9.9 ± 1.1

0.60^*

At 3 M follow-up

5.7 ± 0.8

6.0 ± 0.7

0.24^*

At 6 M follow-up

6.0 ± 0.7

5.8 ± 0.6

0.25^*

CREA (μmol/L)

67.9 ± 21.4

74.8 ± 21.4

0.18^*

UREA (mmol/L)

5.5 ± 1.6

5.7 ± 1.8

0.52^*

eGFR (ml/min)

105.9 ± 15.5

112.0 ± 12.4

0.07^*

TG (mmol/L)

1.8 ± 0.8

1.6 ± 0.7

0.36^*

CHOL (mmol/L)

5.3 ± 1.4

4.9 ± 1.1

0.11^*

Hyperlipidemia

12 (33.3%)

8 (22.2%)

0.43^†

Smoking

13 (36.1%)

10 (27.8%)

0.61^†